EcoDrugPlus

Dihydroorotate Dehydrogenase

Ensembl ID : ENSACIG00000005156
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase B

Ensembl ID : ENSACIG00000001318
Gene Symbol: DPYDB
1 Cross references
217 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSACIG00000024384
Gene Symbol: DDR2
1 Cross references
205 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSACIG00000019080
Gene Symbol: DDR2
1 Cross references
189 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSACIG00000016838
Gene Symbol: DRD1
2 Cross references
189 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSACIG00000000808
Gene Symbol: DRD1B
1 Cross references
201 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSACIG00000001878
Gene Symbol: DRD2A
1 Cross references
207 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSACIG00000021441
Gene Symbol: DRD3
1 Cross references
203 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSACIG00000007389
Gene Symbol: DRD4A
2 Cross references
174 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSACIG00000012717
Gene Symbol: DRD4B
1 Cross references
175 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSACIG00000003404
Gene Symbol: DRD5
2 Cross references
148 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSACIG00000012098
Gene Symbol: ENPP2
1 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).